284 related articles for article (PubMed ID: 30197439)
1. Canine visceral hemangiosarcoma treated with surgery alone or surgery and doxorubicin: 37 cases (2005-2014).
Batschinski K; Nobre A; Vargas-Mendez E; Tedardi MV; Cirillo J; Cestari G; Ubukata R; Dagli MLZ
Can Vet J; 2018 Sep; 59(9):967-972. PubMed ID: 30197439
[TBL] [Abstract][Full Text] [Related]
2. Surgery and doxorubicin in dogs with hemangiosarcoma.
Ogilvie GK; Powers BE; Mallinckrodt CH; Withrow SJ
J Vet Intern Med; 1996; 10(6):379-84. PubMed ID: 8947871
[TBL] [Abstract][Full Text] [Related]
3. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD
BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540
[TBL] [Abstract][Full Text] [Related]
4. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP
J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.
U'Ren LW; Biller BJ; Elmslie RE; Thamm DH; Dow SW
J Vet Intern Med; 2007; 21(1):113-20. PubMed ID: 17338158
[TBL] [Abstract][Full Text] [Related]
6. Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs.
Lana S; U'ren L; Plaza S; Elmslie R; Gustafson D; Morley P; Dow S
J Vet Intern Med; 2007; 21(4):764-9. PubMed ID: 17708397
[TBL] [Abstract][Full Text] [Related]
7. Clinical and pharmacokinetic characteristics of intracavitary administration of pegylated liposomal encapsulated doxorubicin in dogs with splenic hemangiosarcoma.
Sorenmo K; Samluk M; Clifford C; Baez J; Barrett JS; Poppenga R; Overley B; Skorupski K; Oberthaler K; Van Winkle T; Seiler G; Shofer F
J Vet Intern Med; 2007; 21(6):1347-54. PubMed ID: 18196746
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: a pilot study.
Kahn SA; Mullin CM; de Lorimier LP; Burgess KE; Risbon RE; Fred RM; Drobatz K; Clifford CA
Can Vet J; 2013 Mar; 54(3):237-42. PubMed ID: 23997259
[TBL] [Abstract][Full Text] [Related]
9. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.
Vail DM; MacEwen EG; Kurzman ID; Dubielzig RR; Helfand SC; Kisseberth WC; London CA; Obradovich JE; Madewell BR; Rodriguez CO
Clin Cancer Res; 1995 Oct; 1(10):1165-70. PubMed ID: 9815908
[TBL] [Abstract][Full Text] [Related]
10. Current studies of liposome muramyl tripeptide (CGP 19835A lipid) therapy for metastasis in spontaneous tumors: a progress review.
MacEwen EG; Kurzman ID; Helfand S; Vail D; London C; Kisseberth W; Rosenthal RC; Fox LE; Keller ET; Obradovich J
J Drug Target; 1994; 2(5):391-6. PubMed ID: 7704483
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and prognosis of retroperitoneal hemangiosarcoma in dogs with surgical resection with or without adjuvant doxorubicin.
Ichimata M; Toshima A; Matsuyama F; Fukazawa E; Harada K; Katayama R; Kagawa Y; Yamagami T; Kobayashi T
J Vet Med Sci; 2023 Nov; 85(11):1231-1236. PubMed ID: 37853623
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Doxorubicin with or without Metronomic Cyclophosphamide for Canine Splenic Hemangiosarcoma.
Matsuyama A; Poirier VJ; Mantovani F; Foster RA; Mutsaers AJ
J Am Anim Hosp Assoc; 2017; 53(6):304-312. PubMed ID: 28892429
[TBL] [Abstract][Full Text] [Related]
13. Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma.
Finotello R; Stefanello D; Zini E; Marconato L
Vet Comp Oncol; 2017 Mar; 15(1):25-35. PubMed ID: 25623994
[TBL] [Abstract][Full Text] [Related]
14. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993).
Wood CA; Moore AS; Gliatto JM; Ablin LA; Berg RJ; Rand WM
J Am Anim Hosp Assoc; 1998; 34(5):417-21. PubMed ID: 9728473
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma.
Hammer AS; Couto CG; Filppi J; Getzy D; Shank K
J Vet Intern Med; 1991; 5(3):160-6. PubMed ID: 1920253
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL
J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide.
Sorenmo KU; Jeglum KA; Helfand SC
J Vet Intern Med; 1993; 7(6):370-6. PubMed ID: 8114034
[TBL] [Abstract][Full Text] [Related]
18. VAC protocol for treatment of dogs with stage III hemangiosarcoma.
Alvarez FJ; Hosoya K; Lara-Garcia A; Kisseberth W; Couto G
J Am Anim Hosp Assoc; 2013; 49(6):370-7. PubMed ID: 24051260
[TBL] [Abstract][Full Text] [Related]
19. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001-2012).
Wendelburg KM; Price LL; Burgess KE; Lyons JA; Lew FH; Berg J
J Am Vet Med Assoc; 2015 Aug; 247(4):393-403. PubMed ID: 26225611
[TBL] [Abstract][Full Text] [Related]
20. Canine hemangiosarcoma treated with standard chemotherapy and minocycline.
Sorenmo K; Duda L; Barber L; Cronin K; Sammarco C; Usborne A; Goldschmidt M; Shofer F
J Vet Intern Med; 2000; 14(4):395-8. PubMed ID: 10935889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
